Literature DB >> 1540965

Tumor types derived from epithelial and myoepithelial cell lines of R3230AC rat mammary carcinoma.

A Sapino1, M Papotti, B Sanfilippo, P Gugliotta, G Bussolati.   

Abstract

Epithelial and myoepithelial cells coexist in the rat R3230AC mammary tumor. To test the hypothesis that these two cell types constitute interactive but independent neoplastic populations, we obtained in vitro cell lines with epithelial or myoepithelial patterns and transplanted them in syngeneic animals. One stabilized line (EPI) and four cloned lines (A, C, D, E) with epithelial characteristics, confirmed by positive reactions for keratins in immunocytochemical and immunoblot tests, constantly gave rise in vivo to carcinomas, which, however, lacked structural and functional patterns typical of the original tumor. A fusiform shape and immunocytochemical characteristics of myoepithelial cells were observed in three clones (H, I, L), which in vivo gave rise to sarcomatous and mixed carcinosarcomatous neoplasms. These data are consistent with the above hypothesis and indicate that breast carcinomas derive from epithelial cells, while sarcomatous and carcinosarcomatous neoplasms can originate from myoepithelial cell proliferation. This study provides data suggesting myoepithelial cell involvement in the development of pathological entities occurring in the human breast and displaying mixed epithelial and stromal neoplastic components, i.e., cystosarcoma phylloides and sarcomatous metaplasia in carcinomas.

Entities:  

Mesh:

Year:  1992        PMID: 1540965

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Establishment and characterization of a bovine mammary myoepithelial cell line.

Authors:  B Zavizion; M van Duffelen; W Schaeffer; I Politis
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-03       Impact factor: 2.416

2.  Reduced CREB3L1 expression in triple negative and luminal a breast cancer cells contributes to enhanced cell migration, anchorage-independent growth and metastasis.

Authors:  Paul Mellor; Stephanie Kendall; Shari Smith; Anurag Saxena; Deborah H Anderson
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

3.  Oxytocin inhibits proliferation of human breast cancer cell lines.

Authors:  P Cassoni; A Sapino; F Negro; G Bussolati
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast.

Authors:  A Pagani; A Sapino; V Eusebi; P Bergnolo; G Bussolati
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

5.  Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis.

Authors:  Jorge S Reis-Filho; Fernanda Milanezi; Silvia Carvalho; Pete T Simpson; Dawn Steele; Kay Savage; Maryou B K Lambros; Emilio M Pereira; Jahn M Nesland; Sunil R Lakhani; Fernando C Schmitt
Journal:  Breast Cancer Res       Date:  2005-10-25       Impact factor: 6.466

Review 6.  P-cadherin expression in breast cancer: a review.

Authors:  Joana Paredes; Ana Luísa Correia; Ana Sofia Ribeiro; André Albergaria; Fernanda Milanezi; Fernando C Schmitt
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

7.  Cell proliferation and apoptosis in rat mammary cancer after electrochemical treatment (EChT).

Authors:  H von Euler; K Stråhle; A Thörne; G Yongqing
Journal:  Bioelectrochemistry       Date:  2004-04       Impact factor: 5.373

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.